eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Johnson & Johnson Ltd

Foundation Park, Roxborough Way, Maidenhead, Berks, SL6 3UG, UK
Telephone: +44 (0)1628 822 222
Medical Information Direct Line: +44 (0)1344 864 042
Medical Information e-mail: medinfo@congb.jnj.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 11/03/2010
SPC Neutrogena T/Gel Therapeutic Shampoo


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Neutrogena T/Gel Therapeutic Shampoo.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

The shampoo contains Neutar solubilised coal tar extract 20mg/ml (equivalent to 5mg/ml coal tar) as the active ingredient.

For a full list of excipients see section 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Shampoo.

A translucent amber solution.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Treatment for seborrhoeic dermatitis of the scalp, dandruff and scalp psoriasis.


Go to top of the page
4.2 Posology and method of administration

For cutaneous use only. Liberal amounts of Neutrogena T/Gel Therapeutic Shampoo should be applied and massaged into the wet scalp and left for several minutes. The scalp should be rinsed, the application repeated and then the scalp rinsed thoroughly. Neutrogena T/Gel Therapeutic Shampoo should be used two to three times weekly for the treatment of scalp disorders. Treatment usually lasts for 6 weeks, after which time improvement should be seen. Longer periods of treatment should only take place under the supervision of a doctor. Neutrogena T/Gel Therapeutic shampoo is not recommended for use in children below 12 years of age due to insufficient data on safety and efficacy in this age group.


Go to top of the page
4.3 Contraindications

Hypersensitivity to coal tar or to any of the excipients.

Acutely inflamed or broken skin.


Go to top of the page
4.4 Special warnings and precautions for use

If irritation develops, discontinue use and consult a physician.

Contact with eyes should be avoided.

In rare instances, temporary discoloration of blond, bleached or tinted hair may occur.

Coal tar may have a photosensitising action and caution should be exercised in exposing skin to sunlight after use.

Contains parahydroxybenzoates which may cause allergic reactions (possibly delayed).

Contains esters of benzoic acid and benzyl benzoate which can mildly irritate the skin, eyes and mucous membranes.

Contains butylated hydroxytoluene, which may cause local skin reactions (e.g. contact dermatitis) or irritation to the eyes and mucous membranes.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

No interaction studies have been performed.


Go to top of the page
4.6 Pregnancy and lactation

There are no studies to demonstrate the safety of Neutrogena T/Gel Therapeutic Shampoo in human pregnancy. It is recommended that Neutrogena T/Gel Therapeutic Shampoo is not used during pregnancy or while breast-feeding, unless the risks and benefits have been evaluated and discussed with a physician.


Go to top of the page
4.7 Effects on ability to drive and use machines

Not relevant.


Go to top of the page
4.8 Undesirable effects

Coal tar products may cause photosensitisation, skin irritation and acne like skin eruptions. The calculated adverse event rate based on post marketing experience is 0.0002NON-BREAKING HYPHEN (8209)0.0025% making these occurrences very rare (<1/10,000).


Go to top of the page
4.9 Overdose

Not applicable.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Pharmacotherapeutic group: Medicated Shampoo, ATC code: D11 AC 30

No new data are presented


Go to top of the page
5.2 Pharmacokinetic properties

No new data are presented


Go to top of the page
5.3 Preclinical safety data

No new data are presented


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Macrogol lauryl ether (4)

Sodium lauryl ether sulphate

Cocodiethanolamide

Cocamidopropyl betaine

Imidazolidinyl urea

Methyl parahydroxybenzoate (E218)

Propyl parahydroxybenzoate (E216)

Tetrasodium EDTA

Citric acid

Fragrance FUGIO 242156

Sodium chloride

Purified water

*The constituents of the fragrance include esters of benzoic acid, benzyl benzoate and butylated hydroxytoluene (E321).


Go to top of the page
6.2 Incompatibilities

Not applicable


Go to top of the page
6.3 Shelf life

3 years


Go to top of the page
6.4 Special precautions for storage

Store away from direct sunlight. Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

Clear plastic bottle with plastic pop-up cap, or screw top, containing 15, 125, or 250 ml solution.

Not all pack sizes may be marketed.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.

Any unused product or waste material should be disposed of in accordance with local requirements.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Johnson & Johnson Limited

Foundation Park

Roxborough Way

Maidenhead

Berkshire

SL6 3UG


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 08874/0014


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

Date of first authorisation: 30 April 1996

Date of latest renewal: 06 February 2004:


Go to top of the page
10. DATE OF REVISION OF THE TEXT

23 February 2010



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/20920/SPC/


Active Ingredients/Generics

 
   coal tar extract